AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
less 20 24 20 24 O
than 25 29 25 29 O
or 30 32 30 32 O
equal 33 38 33 38 O
to 39 41 39 41 O
3 42 43 42 43 B-upper_bound
times 44 49 44 49 I-upper_bound
institutional 50 63 50 63 I-upper_bound
upper 64 69 64 69 I-upper_bound
limit 70 75 70 75 I-upper_bound
of 76 78 76 78 I-upper_bound
normal 79 85 79 85 I-upper_bound

Age 0 3 86 89 B-age
greater 4 11 90 97 O
than 12 16 98 102 O
or 17 19 103 105 O
equal 20 25 106 111 O
to 26 28 112 114 O
18 29 31 115 117 B-lower_bound
years 32 37 118 123 I-lower_bound
of 38 40 124 126 O
age 41 44 127 130 B-age

Any 0 3 131 134 O
gastrointestinal 4 20 135 151 B-chronic_disease
disease 21 28 152 159 I-chronic_disease
which 29 34 160 165 O
would 35 40 166 171 O
impair 41 47 172 178 O
ability 48 55 179 186 O
to 56 58 187 189 O
swallow 59 66 190 197 O
, 66 67 197 198 O
retain 68 74 199 205 O
, 74 75 205 206 O
or 76 78 207 209 O
absorb 79 85 210 216 O
drug 86 90 217 221 O
is 91 93 222 224 O
not 94 97 225 228 O
allowed 98 105 229 236 O

ECOG 0 4 237 241 B-clinical_variable
performance 5 16 242 253 I-clinical_variable
status 17 23 254 260 I-clinical_variable
less 24 28 261 265 O
than 29 33 266 270 O
or 34 36 271 273 O
equal 37 42 274 279 O
to 43 45 280 282 O
2 46 47 283 284 B-upper_bound

Eligibility 0 11 285 296 O
of 12 14 297 299 O
subjects 15 23 300 308 O
receiving 24 33 309 318 O
any 34 37 319 322 O
medications 38 49 323 334 B-treatment
or 50 52 335 337 O
substances 53 63 338 348 O
with 64 68 349 353 O
the 69 72 354 357 O
potential 73 82 358 367 O
to 83 85 368 370 O
affect 86 92 371 377 O
the 93 96 378 381 O
activity 97 105 382 390 O
or 106 108 391 393 O
pharmacokinetics 109 125 394 410 O
of 126 128 411 413 O
BMN 129 132 414 417 B-treatment
673 133 136 418 421 I-treatment
will 137 141 422 426 O
be 142 144 427 429 O
determined 145 155 430 440 O
following 156 165 441 450 O
review 166 172 451 457 O
by 173 175 458 460 O
the 176 179 461 464 O
principal 180 189 465 474 O
investigator 190 202 475 487 O

HIV 0 3 488 491 B-chronic_disease
- 3 4 491 492 O
positive 4 12 492 500 O
patients 13 21 501 509 O
on 22 24 510 512 O
combination 25 36 513 524 B-treatment
antiretroviral 37 51 525 539 I-treatment
therapy 52 59 540 547 I-treatment
are 60 63 548 551 O
ineligible 64 74 552 562 O

Life 0 4 563 567 B-clinical_variable
expectancy 5 15 568 578 I-clinical_variable
of 16 18 579 581 O
greater 19 26 582 589 O
than 27 31 590 594 O
3 32 33 595 596 B-lower_bound
months 34 40 597 603 I-lower_bound

Patients 0 8 604 612 O
who 9 12 613 616 O
are 13 16 617 620 O
receiving 17 26 621 630 O
any 27 30 631 634 O
other 31 36 635 640 O
investigational 37 52 641 656 B-treatment
agents 53 59 657 663 I-treatment

Patients 0 8 664 672 O
who 9 12 673 676 O
have 13 17 677 681 O
had 18 21 682 685 O
chemotherapy 22 34 686 698 B-treatment
or 35 37 699 701 O
radiotherapy 38 50 702 714 B-treatment

Patients 0 8 715 723 O
who 9 12 724 727 O
have 13 17 728 732 O
had 18 21 733 736 O
prior 22 27 737 742 B-treatment
treatment 28 37 743 752 I-treatment
with 38 42 753 757 I-treatment
any 43 46 758 761 I-treatment
PARP 47 51 762 766 I-treatment
inhibitors 52 62 767 777 I-treatment
are 63 66 778 781 O
ineligible 67 77 782 792 O

Patients 0 8 793 801 O
who 9 12 802 805 O
require 13 20 806 813 O
use 21 24 814 817 O
of 25 27 818 820 O
coumarin 28 36 821 829 O
- 36 37 829 830 O
derivative 37 47 830 840 O
anticoagulants 48 62 841 855 B-treatment
such 63 67 856 860 O
as 68 70 861 863 O
warfarin 71 79 864 872 B-treatment
are 80 83 873 876 O
excluded 84 92 877 885 O

Patients 0 8 886 894 O
whose 9 14 895 900 O
brain 15 20 901 906 B-cancer
metastatic 21 31 907 917 I-cancer
disease 32 39 918 925 I-cancer
status 40 46 926 932 O
has 47 50 933 936 O
remained 51 59 937 945 O
stable 60 66 946 952 O
for 67 70 953 956 O
greater 71 78 957 964 O
than 79 83 965 969 O
or 84 86 970 972 O
equal 87 92 973 978 O
to 93 95 979 981 O
4 96 97 982 983 B-lower_bound
weeks 98 103 984 989 I-lower_bound
following 104 113 990 999 O
treatment 114 123 1000 1009 B-treatment
of 124 126 1010 1012 O
brain 127 132 1013 1018 B-cancer
metastases 133 143 1019 1029 I-cancer
are 144 147 1030 1033 O
eligible 148 156 1034 1042 O
to 157 159 1043 1045 O
participate 160 171 1046 1057 O
at 172 174 1058 1060 O
the 175 178 1061 1064 O
discretion 179 189 1065 1075 O
of 190 192 1076 1078 O
the 193 196 1079 1082 O
principal 197 206 1083 1092 O
investigator 207 219 1093 1105 O

Patients 0 8 1106 1114 O
with 9 13 1115 1119 O
HER2 14 18 1120 1124 B-cancer
- 18 19 1124 1125 O
positive 19 27 1125 1133 O
advanced 28 36 1134 1142 O
breast 37 43 1143 1149 B-cancer
cancer 44 50 1150 1156 I-cancer
or 51 53 1157 1159 O
ovarian 54 61 1160 1167 B-cancer
cancer 62 68 1168 1174 I-cancer
should 69 75 1175 1181 O
have 76 80 1182 1186 O
received 81 89 1187 1195 O
at 90 92 1196 1198 O
least 93 98 1199 1204 O
two 99 102 1205 1208 O
lines 103 108 1209 1214 O
of 109 111 1215 1217 O
systemic 112 120 1218 1226 O
therapy 121 128 1227 1234 B-treatment
in 129 131 1235 1237 O
the 132 135 1238 1241 O
advanced 136 144 1242 1250 O
setting 145 152 1251 1258 O

Patients 0 8 1259 1267 O
with 9 13 1268 1272 O
known 14 19 1273 1278 O
active 20 26 1279 1285 O
brain 27 32 1286 1291 B-cancer
metastases 33 43 1292 1302 I-cancer
or 44 46 1303 1305 O
carcinomatous 47 60 1306 1319 B-cancer
meningitis 61 71 1320 1330 I-cancer
are 72 75 1331 1334 O
excluded 76 84 1335 1343 O
from 85 89 1344 1348 O
this 90 94 1349 1353 O
clinical 95 103 1354 1362 O
trial 104 109 1363 1368 O

Pregnant 0 8 1369 1377 B-pregnancy
women 9 14 1378 1383 B-gender
are 15 18 1384 1387 O
excluded 19 27 1388 1396 O
from 28 32 1397 1401 O
this 33 37 1402 1406 O
study 38 43 1407 1412 O

Uncontrolled 0 12 1413 1425 O
intercurrent 13 25 1426 1438 O
illness 26 33 1439 1446 O
including 34 43 1447 1456 O
, 43 44 1456 1457 O
but 45 48 1458 1461 O
not 49 52 1462 1465 O
limited 53 60 1466 1473 O
to 61 63 1474 1476 O
, 63 64 1476 1477 O
ongoing 65 72 1478 1485 O
or 73 75 1486 1488 O
active 76 82 1489 1495 B-chronic_disease
infection 83 92 1496 1505 I-chronic_disease
, 92 93 1505 1506 O
symptomatic 94 105 1507 1518 B-chronic_disease
congestive 106 116 1519 1529 I-chronic_disease
heart 117 122 1530 1535 I-chronic_disease
failure 123 130 1536 1543 I-chronic_disease
, 130 131 1543 1544 O
unstable 132 140 1545 1553 B-chronic_disease
angina 141 147 1554 1560 I-chronic_disease
pectoris 148 156 1561 1569 I-chronic_disease
, 156 157 1569 1570 O
cardiac 158 165 1571 1578 B-chronic_disease
arrhythmia 166 176 1579 1589 I-chronic_disease
, 176 177 1589 1590 O
or 178 180 1591 1593 O
psychiatric 181 192 1594 1605 B-chronic_disease
illness 193 200 1606 1613 I-chronic_disease
/ 200 201 1613 1614 O
social 201 207 1614 1620 O
situations 208 218 1621 1631 O
that 219 223 1632 1636 O
would 224 229 1637 1642 O
limit 230 235 1643 1648 O
compliance 236 246 1649 1659 O
with 247 251 1660 1664 O
study 252 257 1665 1670 O
requirements 258 270 1671 1683 O

Women 0 5 1684 1689 B-gender
who 6 9 1690 1693 O
are 10 13 1694 1697 O
currently 14 23 1698 1707 O
lactating 24 33 1708 1717 O

absolute 0 8 1718 1726 B-clinical_variable
neutrophil 9 19 1727 1737 I-clinical_variable
count 20 25 1738 1743 I-clinical_variable
greater 26 33 1744 1751 O
than 34 38 1752 1756 O
or 39 41 1757 1759 O
equal 42 47 1760 1765 O
to 48 50 1766 1768 O
1,500 51 56 1769 1774 B-lower_bound
/ 56 57 1774 1775 I-lower_bound
mcL 57 60 1775 1778 I-lower_bound

creatinine 0 10 1779 1789 B-clinical_variable
clearance 11 20 1790 1799 I-clinical_variable
greater 21 28 1800 1807 O
than 29 33 1808 1812 O
or 34 36 1813 1815 O
equal 37 42 1816 1821 O
to 43 45 1822 1824 O
60 46 48 1825 1827 B-lower_bound
mL 49 51 1828 1830 I-lower_bound
/ 51 52 1830 1831 I-lower_bound
min 52 55 1831 1834 I-lower_bound
for 56 59 1835 1838 O
patients 60 68 1839 1847 O
with 69 73 1848 1852 O
creatinine 74 84 1853 1863 B-clinical_variable
levels 85 91 1864 1870 I-clinical_variable
above 92 97 1871 1876 O
institutional 98 111 1877 1890 O
normal 112 118 1891 1897 O

creatinine 0 10 1898 1908 B-clinical_variable
less 11 15 1909 1913 O
than 16 20 1914 1918 O
or 21 23 1919 1921 O
equal 24 29 1922 1927 O
to 30 32 1928 1930 O
1.5 33 36 1931 1934 B-upper_bound
times 37 42 1935 1940 I-upper_bound
institutional 43 56 1941 1954 I-upper_bound
upper 57 62 1955 1960 I-upper_bound
limit 63 68 1961 1966 I-upper_bound
of 69 71 1967 1969 I-upper_bound
normal 72 78 1970 1976 I-upper_bound

for 0 3 1977 1980 O
the 4 7 1981 1984 O
duration 8 16 1985 1993 O
of 17 19 1994 1996 O
study 20 25 1997 2002 O
participation 26 39 2003 2016 O
, 39 40 2016 2017 O
and 41 44 2018 2021 O
for 45 48 2022 2025 O
30 49 51 2026 2028 O
days 52 56 2029 2033 O
after 57 62 2034 2039 O
completing 63 73 2040 2050 O
study 74 79 2051 2056 O
treatment 80 89 2057 2066 B-treatment

leukocytes 0 10 2067 2077 B-clinical_variable
greater 11 18 2078 2085 O
than 19 23 2086 2090 O
or 24 26 2091 2093 O
equal 27 32 2094 2099 O
to 33 35 2100 2102 O
3,000 36 41 2103 2108 B-lower_bound
/ 41 42 2108 2109 I-lower_bound
mcL 42 45 2109 2112 I-lower_bound

platelets 0 9 2113 2122 B-clinical_variable
greater 10 17 2123 2130 O
than 18 22 2131 2135 O
or 23 25 2136 2138 O
equal 26 31 2139 2144 O
to 32 34 2145 2147 O
100,000 35 42 2148 2155 B-lower_bound
/ 42 43 2155 2156 I-lower_bound
mcL 43 46 2156 2159 I-lower_bound

total 0 5 2160 2165 O
bilirubin 6 15 2166 2175 B-clinical_variable
less 16 20 2176 2180 O
than 21 25 2181 2185 O
or 26 28 2186 2188 O
equal 29 34 2189 2194 O
to 35 37 2195 2197 O
1.5 38 41 2198 2201 B-upper_bound
times 42 47 2202 2207 I-upper_bound
institutional 48 61 2208 2221 B-clinical_variable
upper 62 67 2222 2227 I-clinical_variable
limit 68 73 2228 2233 I-clinical_variable
of 74 76 2234 2236 I-clinical_variable
normal 77 83 2237 2243 I-clinical_variable

within 0 6 2244 2250 O
4 7 8 2251 2252 O
weeks 9 14 2253 2258 O
( 15 16 2259 2260 O
6 16 17 2260 2261 B-upper_bound
weeks 18 23 2262 2267 I-upper_bound
for 24 27 2268 2271 O
nitrosoureas 28 40 2272 2284 B-treatment
or 41 43 2285 2287 O
mitomycin 44 53 2288 2297 B-treatment
C 54 55 2298 2299 I-treatment
) 55 56 2299 2300 O
prior 57 62 2301 2306 O
to 63 65 2307 2309 O
entering 66 74 2310 2318 O
the 75 78 2319 2322 O
study 79 84 2323 2328 O
or 85 87 2329 2331 O
those 88 93 2332 2337 O
who 94 97 2338 2341 O
have 98 102 2342 2346 O
not 103 106 2347 2350 O
recovered 107 116 2351 2360 O
from 117 121 2361 2365 O
adverse 122 129 2366 2373 O
events 130 136 2374 2380 O
due 137 140 2381 2384 O
to 141 143 2385 2387 O
agents 144 150 2388 2394 O
administered 151 163 2395 2407 O
more 164 168 2408 2412 O
than 169 173 2413 2417 O
4 174 175 2418 2419 O
weeks 176 181 2420 2425 O
earlier 182 189 2426 2433 O

women 0 5 2434 2439 B-gender
of 6 8 2440 2442 O
childbearing 9 21 2443 2455 O
potential 22 31 2456 2465 O
and 32 35 2466 2469 O
men 36 39 2470 2473 O
must 40 44 2474 2478 O
agree 45 50 2479 2484 B-contraception_consent
to 51 53 2485 2487 I-contraception_consent
use 54 57 2488 2491 I-contraception_consent
adequate 58 66 2492 2500 I-contraception_consent
contraception 67 80 2501 2514 I-contraception_consent
( 81 82 2515 2516 I-contraception_consent
hormonal 82 90 2516 2524 I-contraception_consent
or 91 93 2525 2527 I-contraception_consent
barrier 94 101 2528 2535 I-contraception_consent
method 102 108 2536 2542 I-contraception_consent
of 109 111 2543 2545 I-contraception_consent
birth 112 117 2546 2551 I-contraception_consent
control 118 125 2552 2559 I-contraception_consent
; 125 126 2559 2560 I-contraception_consent
abstinence 127 137 2561 2571 I-contraception_consent
) 137 138 2571 2572 I-contraception_consent
prior 139 144 2573 2578 O
to 145 147 2579 2581 O
study 148 153 2582 2587 O
entry 154 159 2588 2593 O

